Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kiniksa Pharmaceuticals International, plc (KNSA)
USD61.90
-0.09 (-0.14%)
GB NASDAQ Healthcare Medical - Pharmaceuticals
Address
105 Piccadilly W1J 7NJ
London, MA, GB
London, MA, GB
CEO
Sanj K. Patel
Website
kiniksa.com
IPO
2018-05-24
CIK 1730430 ISIN GB00BRXB0C07
Description
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
News Sentiment (7d)
Based on only 1 article — low confidence
- Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD61.90
-0.09 (-0.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
807.0K
Beta
0.12
Float Shares
71.87M
Free Float %
95.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.84% | -9.13% | -10.04% | +8.74% | +13.78% | +17.28% | +76.83% | +253.91% | +265.41% | +148.48% | +148.48% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
61.90
Low
59.00
-4.7%
Consensus
64.00
+3.4%
Median
62.00
+0.2%
High
71.00
+14.7%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 3 |
62.67
+1.3%
|
| Last Year | 8 |
56.63
-8.5%
|
| All Time | 11 |
51.09
-17.5%
|
Quality scores
Altman Z-Score
11.14
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%+60.1% ★ Q1'26: +55.5% (vs Q1'25)
-
EPS growth Medical - Pharmaceuticals: +20.2%+225.0% ★ Q1'26: +145.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%+16.5% Q1'26: +23.4% (vs Q1'25)
-
EBIT margin Medical - Pharmaceuticals: +6.8%+13.1% ★ Q1'26: +13.7% (vs Q1'25)
-
ROIC Medical - Pharmaceuticals: +6.1%+36.2% ★ Q1'26: +55.2% (vs Q1'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%+10.6% Q1'26: +8.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×0.11× ★ Q1'26: 0.08× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 4 EPS Ana. |
Dec 2028 7 Rev. Ana. 6 EPS Ana. |
Dec 2029 3 Rev. Ana. 4 EPS Ana. |
Dec 2030 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
38.54M
est: 37.40M (+3.1%)
|
220.18M
est: 203.34M (+8.3%)
|
270.26M
est: 338.93M (-20.3%)
|
423.24M
est: 424.18M (-0.2%)
|
677.56M
est: 676.45M (+0.2%)
|
939.49M
937.45M – 941.52M
+38.9% YoY
|
1.13B
1.12B – 1.14B
+19.9% YoY
|
1.27B
1.27B – 1.27B
+12.6% YoY
|
1.43B
1.41B – 1.44B
+12.3% YoY
|
1.58B
1.57B – 1.60B
+10.9% YoY
|
| EBITDA |
-154.28M
est: -159.24M (+3.1%)
|
12.18M
est: -135.04M (+109.0%)
|
-22.86M
est: -67.76M (+66.3%)
|
-43.92M
est: -84.80M (+48.2%)
|
90.42M
est: -135.23M (+166.9%)
|
-187.82M
-188.23M – -187.41M
-38.9% YoY
|
-225.20M
-227.18M – -223.31M
-19.9% YoY
|
-253.64M
-253.64M – -253.64M
-12.6% YoY
|
-284.89M
-287.79M – -282.49M
-12.3% YoY
|
-315.82M
-319.03M – -313.16M
-10.9% YoY
|
| EBIT |
-156.64M
est: -161.78M (+3.2%)
|
9.77M
est: -138.05M (+107.1%)
|
-25.20M
est: -69.51M (+63.8%)
|
-45.62M
est: -87.00M (+47.6%)
|
88.87M
est: -138.73M (+164.1%)
|
-192.68M
-193.10M – -192.26M
-38.9% YoY
|
-231.03M
-233.06M – -229.09M
-19.9% YoY
|
-260.20M
-260.21M – -260.20M
-12.6% YoY
|
-292.26M
-295.24M – -289.80M
-12.3% YoY
|
-323.99M
-327.29M – -321.26M
-10.9% YoY
|
| Net Income |
-157.92M
est: -163.10M (+3.2%)
|
183.36M
est: -141.18M (+229.9%)
|
14.08M
est: -11.46M (+222.8%)
|
-43.19M
est: -29.11M (-48.4%)
|
59.01M
est: 73.06M (-19.2%)
|
101.23M
100.51M – 118.86M
+38.6% YoY
|
143.30M
109.97M – 178.59M
+41.6% YoY
|
187.77M
115.44M – 244.21M
+31.0% YoY
|
233.38M
230.83M – 236.47M
+24.3% YoY
|
350.07M
346.25M – 354.71M
+50.0% YoY
|
| SGA |
85.95M
est: 34.04M (+152.5%)
|
97.95M
est: 93.63M (+4.6%)
|
129.43M
est: 260.32M (-50.3%)
|
168.01M
est: 325.79M (-48.4%)
|
196.27M
est: 519.55M (-62.2%)
|
721.58M
720.01M – 723.14M
+38.9% YoY
|
865.18M
857.91M – 872.77M
+19.9% YoY
|
974.45M
974.45M – 974.45M
+12.6% YoY
|
1.09B
1.09B – 1.11B
+12.3% YoY
|
1.21B
1.20B – 1.23B
+10.9% YoY
|
| EPS |
-2.30
est: -2.18 (-5.3%)
|
2.64
est: 2.38 (+10.9%)
|
0.20
est: -0.15 (+237.9%)
|
-0.60
est: -0.39 (-52.4%)
|
0.80
est: 0.97 (-17.9%)
|
1.37
1.27 – 1.50
+40.9% YoY
|
1.89
1.39 – 2.26
+38.0% YoY
|
2.50
1.46 – 3.09
+31.8% YoY
|
2.96
2.92 – 2.99
+18.4% YoY
|
4.43
4.38 – 4.49
+50.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-29 | Citigroup | Buy | Buy | Maintain |
| 2026-04-28 | Jefferies | Buy | Buy | Maintain |
| 2026-04-16 | Wedbush | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B | 3/5 | 1/5 | 4/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 4/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
175.92M
OE per share TTM
2.21
Owner's Yield
4.75%
Maintenance CapEx ratio
13.79%
Maint CapEx / Avg PPE
4.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
233
Total invested
2.18B
Insider transactions (90d)
6
Beneficial owners (>5%)
31
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1)Names of reporting persons. BlackRock, Inc. | 3.57M | 5.10% | 3.39M | — | 3.57M | — | HC | Delaware | 2022-09-08 | ↗ |
| 2 | Felix J. Baker | 3.15M | 7.70% | 3.15M | — | 3.15M | — | HC, IN | United States | 2024-10-08 | ↗ |
| 3 | Julian C. Baker | 3.15M | 7.70% | 3.15M | — | 3.15M | — | HC, IN | United States | 2024-10-08 | ↗ |
| 4 | Baker Bros. Advisors (GP) LLC | 3.13M | 7.60% | 3.13M | — | 3.13M | — | HC, OO | Delaware | 2024-10-08 | ↗ |
| 5 | Baker Bros. Advisors LP | 3.13M | 7.60% | 3.13M | — | 3.13M | — | IA, PN | Delaware | 2024-10-08 | ↗ |
| 6 | David Rosen | 2.91M | 8.21% | — | 2.91M | — | — | IN | United States of America | 2024-02-12 | ↗ |
| 7 | LP | 2.91M | 8.21% | — | 2.91M | — | — | IA, PN | State of Delaware | 2024-02-12 | ↗ |
| 8 | The Vanguard Group - 23-1945930 | 2.89M | 8.53% | — | 35.9K | 2.84M | 53.4K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 9 | Fairmount Funds Management LLC | 2.14M | 6.10% | — | 2.14M | — | — | IA | Delaware | 2023-08-10 | ↗ |
| 10 | Peter Harwin | 2.14M | 6.10% | — | 2.14M | — | — | HC, IN | United States | 2023-08-10 | ↗ |
| 11 | Tomas Kiselak | 2.14M | 6.10% | — | 2.14M | — | — | HC, IN | Slovak Republic | 2023-08-10 | ↗ |
| 12 | Fairmount Healthcare Fund II L.P. | 2.09M | 5.90% | — | 2.09M | — | — | PN | Delaware | 2023-08-10 | ↗ |
| 13 | Hillhouse Capital Advisors, Ltd. | 1.39M | 8.80% | 1.39M | — | 1.39M | — | IA | Cayman Islands | 2019-02-14 | ↗ |
| 14 | Consonance Capman GP LLC | 1.25M | 3.99% | — | 1.25M | — | — | HC, OO | Delaware USA | 2020-11-05 | ↗ |
| 15 | Mitchell Blutt | 1.25M | 3.99% | — | 1.25M | — | — | HC, IN | Delaware USA | 2020-11-05 | ↗ |
| 16 | The reporting person disclaim beneficial ownership of the shares reported, which are owned of record | 1.23M | 3.57% | 1.23M | — | 1.23M | — | — | Switzerland | 2023-02-03 | ↗ |
| 17 | Consonance Capital Management LP | 1.20M | 3.84% | — | 1.20M | — | — | IA, PN | Delaware USA | 2020-11-05 | ↗ |
| 18 | ArrowMark Colorado Holdings, LLC | 1.16M | 3.70% | 1.16M | — | 1.16M | — | IA | Delaware, United States | 2021-02-16 | ↗ |
| 19 | No. 13-3180631 | 1.15M | 5.99% | — | 1.15M | — | 1.15M | HC | Delaware | 2020-02-14 | ↗ |
| 20 | No. 41-1533211 | 1.15M | 5.99% | — | 1.15M | — | 1.15M | IA | Delaware | 2020-02-14 | ↗ |
| 21 | No. 04-3519872 | 1.13M | 5.87% | — | 1.13M | — | 1.13M | IA | Delaware | 2020-02-14 | ↗ |
| 22 | : Robert Desnick | 932.9K | 5.80% | 534.3K | 398.6K | 534.3K | — | IN | U.S. | 2018-07-19 | ↗ |
| 23 | Bihua Chen | 831.0K | 4.50% | — | 831.0K | — | — | IN | United States | 2019-02-14 | ↗ |
| 24 | Cormorant Asset Management, LP | 831.0K | 4.50% | — | 831.0K | — | — | PN | Delaware | 2019-02-14 | ↗ |
| 25 | Cormorant Private Healthcare Fund I, LP | 640.6K | 3.47% | — | 640.6K | — | — | PN | Delaware | 2019-02-14 | ↗ |
| 26 | Cormorant Private Healthcare GP, LLC | 640.6K | 3.47% | — | 640.6K | — | — | OO | Delaware | 2019-02-14 | ↗ |
| 27 | Cormorant Global Healthcare GP, LLC | 162.0K | 0.88% | — | 162.0K | — | — | OO | Delaware | 2019-02-14 | ↗ |
| 28 | Cormorant Global Healthcare Master Fund, LP | 162.0K | 0.88% | — | 162.0K | — | — | PN | Cayman Islands | 2019-02-14 | ↗ |
| 29 | Fairmount Healthcare Fund L.P. | 57.1K | 0.20% | — | 57.1K | — | — | PN | Delaware | 2023-08-10 | ↗ |
| 30 | Consonance Capital Opportunity Fund Management LP | 47.6K | 0.15% | — | 47.6K | — | — | IA, PN | Delaware USA | 2020-11-05 | ↗ |
| 31 | FBB3 LLC | 7.3K | 0.02% | 7.3K | — | 7.3K | — | OO | Delaware | 2024-10-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
233
+6 vs prev Q
New positions
42
Closed positions
36
Increased
116
Reduced
87
Put/Call ratio
0.02
Calls held
1.07M
Puts held
23.5K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 435.0K +435.0K (+100.0%) | 17.94B +17.9B (+100.0%) | 0.59% +0.591 pp | 5.93% +5.928 pp | USD41.25 +0.0% | 1 qtrs NEW |
| 2 | RUBRIC CAPITAL MANAGEMENT LP | 3.33M -671.3K (-16.8%) | 137.31M -18.0M (-11.6%) | 4.52% -0.924 pp | 1.64% -0.110 pp | USD20.64 +99.9% | 7 qtrs — |
| 3 | VANGUARD GROUP INC | 3.11M +49.8K (+1.6%) | 128.41M +9.5M (+8.0%) | 4.23% +0.058 pp | 0.00% +0.000 pp | USD25.13 +64.1% | 6 qtrs — |
| 4 | BAKER BROS. ADVISORS LP | 2.83M +1.6K (+0.1%) | 116.58M +6.9M (+6.3%) | 3.84% -0.007 pp | 0.68% -0.110 pp | USD18.03 +128.8% | 7 qtrs — |
| 5 | TANG CAPITAL MANAGEMENT LLC | 2.26M -68.7K (-3.0%) | 93.22M +2.8M (+3.1%) | 3.07% -0.101 pp | 4.60% +1.124 pp | USD21.58 +91.1% | 7 qtrs — |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 1.71M +94.5K (+5.8%) | 70.63M +7.8M (+12.4%) | 2.33% +0.123 pp | 0.12% +0.006 pp | USD26.95 +53.1% | 7 qtrs — |
| 7 | FMR LLC | 1.64M +843.1K (+105.4%) | 67.77M +36.7M (+118.2%) | 2.23% +1.143 pp | 0.00% +0.002 pp | USD33.14 +24.5% | 7 qtrs — |
| 8 | CAPTION MANAGEMENT, LLC | 1.49M +987.9K (+196.6%) | 61.48M +42.0M (+215.0%) | 2.03% +1.341 pp | 0.42% +0.269 pp | USD38.60 +6.9% | 6 qtrs — |
| 9 | MORGAN STANLEY | 1.36M -2.9K (-0.2%) | 56.10M +3.2M (+6.0%) | 1.85% -0.008 pp | 0.00% +0.000 pp | USD22.97 +79.6% | 7 qtrs — |
| 10 | FAIRMOUNT FUNDS MANAGEMENT LLC | 1.32M -453.2K (-25.6%) | 54.44M -14.4M (-20.9%) | 1.79% -0.621 pp | 4.14% -2.050 pp | USD21.66 +90.4% | 7 qtrs — |
| 11 | D. E. SHAW & CO., INC. | 1.24M +107.4K (+9.5%) | 51.22M +7.2M (+16.3%) | 1.69% +0.143 pp | 0.03% +0.003 pp | USD29.94 +37.8% | 7 qtrs — |
| 12 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.07M -47.0 (0.0%) | 44.06M +2.6M (+6.2%) | 1.45% -0.003 pp | 0.03% 0.000 pp | USD31.15 +32.4% | 7 qtrs — |
| 13 | BNP PARIBAS ARBITRAGE, SNC | 831.8K +178.4K (+27.3%) | 34.31M +8.9M (+35.2%) | 1.13% +0.240 pp | 0.02% +0.002 pp | USD32.08 +28.6% | 7 qtrs — |
| 14 | GOLDMAN SACHS GROUP INC | 829.4K +282.9K (+51.8%) | 34.21M +13.0M (+61.2%) | 1.13% +0.383 pp | 0.00% +0.002 pp | USD33.99 +21.4% | 6 qtrs — |
| 15 | MILLENNIUM MANAGEMENT LLC | 825.3K -188.8K (-18.6%) | 34.04M -5.3M (-13.5%) | 1.12% -0.260 pp | 0.01% -0.003 pp | USD20.38 +102.4% | 7 qtrs — |
| 16 | POINT72 ASSET MANAGEMENT, L.P. | 797.1K +230.2K (+40.6%) | 32.88M +10.9M (+49.4%) | 1.08% +0.311 pp | 0.04% 0.000 pp | USD27.71 +48.9% | 4 qtrs — |
| 17 | PICTET ASSET MANAGEMENT HOLDING SA | 787.5K -144.6K (-15.5%) | 32.49M -3.7M (-10.2%) | 1.07% -0.199 pp | 0.03% -0.003 pp | USD18.00 +129.2% | 7 qtrs — |
| 18 | QUBE RESEARCH & TECHNOLOGIES LTD | 766.3K +76.4K (+11.1%) | 31.61M +4.8M (+18.0%) | 1.04% +0.102 pp | 0.03% +0.004 pp | USD28.29 +45.8% | 6 qtrs — |
| 19 | CITADEL ADVISORS LLC | 742.1K +427.6K (+135.9%) | 30.61M +18.4M (+150.6%) | 1.01% +0.580 pp | 0.00% +0.003 pp | USD35.73 +15.4% | 7 qtrs — |
| 20 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 739.3K +14.0K (+1.9%) | 30.50M +2.3M (+8.3%) | 1.00% +0.017 pp | 0.08% -0.009 pp | USD25.59 +61.2% | 7 qtrs — |
| 21 | DIMENSIONAL FUND ADVISORS LP | 683.5K +51.4K (+8.1%) | 28.19M +3.6M (+14.9%) | 0.93% +0.068 pp | 0.01% +0.001 pp | USD20.47 +101.5% | 7 qtrs — |
| 22 | PARKMAN HEALTHCARE PARTNERS LLC | 665.2K -6.4K (-1.0%) | 27.44M +1.4M (+5.2%) | 0.90% -0.011 pp | 2.61% -0.108 pp | USD24.41 +69.0% | 7 qtrs — |
| 23 | DRIEHAUS CAPITAL MANAGEMENT LLC | 632.8K -21.8K (-3.3%) | 26.10M +686.6K (+2.7%) | 0.86% -0.032 pp | 0.18% -0.005 pp | USD19.78 +108.5% | 7 qtrs — |
| 24 | DEUTSCHE BANK AG\ | 630.3K +96.9K (+18.2%) | 26.00M +5.3M (+25.5%) | 0.86% +0.130 pp | 0.01% +0.002 pp | USD29.57 +39.5% | 6 qtrs — |
| 25 | RICE HALL JAMES & ASSOCIATES, LLC | 596.4K +18.6K (+3.2%) | 24.60M +2.2M (+9.7%) | 0.81% +0.024 pp | 1.35% +0.131 pp | USD19.43 +112.3% | 7 qtrs — |
| 26 | SOLEUS CAPITAL MANAGEMENT, L.P. | 587.0K +437.0K (+291.3%) | 24.21M +18.4M (+315.7%) | 0.80% +0.593 pp | 0.89% +0.600 pp | USD36.38 +13.4% | 7 qtrs — |
| 27 | SG AMERICAS SECURITIES, LLC | 541.4K +402.1K (+288.6%) | 22.33M +16.9M (+312.8%) | 0.74% +0.546 pp | 0.03% +0.010 pp | USD37.75 +9.3% | 7 qtrs — |
| 28 | TWO SIGMA INVESTMENTS, LP | 530.5K +68.7K (+14.9%) | 21.88M +4.0M (+22.0%) | 0.72% +0.092 pp | 0.03% +0.004 pp | USD35.70 +15.5% | 3 qtrs — |
| 29 | VICTORY CAPITAL MANAGEMENT INC | 512.2K +512.2K (+100.0%) | 21.13M +21.1M (+100.0%) | 0.70% +0.696 pp | 0.01% +0.012 pp | USD41.25 +0.0% | 7 qtrs — |
| 30 | BLACKROCK, INC. | 446.6K -11.0K (-2.4%) | 18.42M +651.9K (+3.7%) | 0.61% -0.016 pp | 0.00% +0.000 pp | USD24.99 +65.1% | 6 qtrs — |
| 31 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 425.2K -33.1K (-7.2%) | 17.54M -255.1K (-1.4%) | 0.58% -0.046 pp | 0.01% +0.000 pp | USD35.93 +14.8% | 7 qtrs — |
| 32 | NOMURA HOLDINGS INC | 412.6K +15.5K (+3.9%) | 17.02M +1.6M (+10.4%) | 0.56% +0.020 pp | 0.02% -0.001 pp | USD38.92 +6.0% | 2 qtrs — |
| 33 | ABRDN PLC | 400.6K +241.9K (+152.4%) | 16.52M +10.4M (+168.1%) | 0.54% +0.328 pp | 0.03% +0.016 pp | USD40.29 +2.4% | 2 qtrs — |
| 34 | AQR CAPITAL MANAGEMENT LLC | 353.1K +20.6K (+6.2%) | 14.56M +1.7M (+12.8%) | 0.48% +0.027 pp | 0.01% -0.001 pp | USD22.56 +82.8% | 7 qtrs — |
| 35 | LOGOS GLOBAL MANAGEMENT LP | 350.0K +350.0K (+100.0%) | 14.44M +14.4M (+100.0%) | 0.48% +0.476 pp | 0.87% +0.872 pp | USD41.25 +0.0% | 1 qtrs NEW |
| 36 | ARROWMARK COLORADO HOLDINGS LLC | 333.7K -6.9K (-2.0%) | 13.77M +538.7K (+4.1%) | 0.45% -0.011 pp | 0.30% +0.057 pp | USD18.11 +127.8% | 7 qtrs — |
| 37 | ALLIANCEBERNSTEIN L.P. | 328.3K +328.3K (+100.0%) | 13.54M +13.5M (+100.0%) | 0.45% +0.446 pp | 0.00% +0.004 pp | USD41.25 +0.0% | 1 qtrs NEW |
| 38 | GRANAHAN INVESTMENT MANAGEMENT, LLC | 316.2K +32.6K (+11.5%) | 13.04M +2.0M (+18.5%) | 0.43% +0.044 pp | 0.56% +0.108 pp | USD20.40 +102.2% | 7 qtrs — |
| 39 | BRAIDWELL LP | 313.8K -329.4K (-51.2%) | 12.95M -12.0M (-48.2%) | 0.43% -0.449 pp | 0.41% -0.327 pp | USD19.98 +106.5% | 7 qtrs — |
| 40 | OBERWEIS ASSET MANAGEMENT INC/ | 312.8K +7.6K (+2.5%) | 12.90M +1.1M (+8.9%) | 0.43% +0.009 pp | 0.47% +0.018 pp | USD25.36 +62.7% | 6 qtrs — |
| 41 | FISHER ASSET MANAGEMENT, LLC | 267.3K -15.0K (-5.3%) | 11.03M +63.8K (+0.6%) | 0.36% -0.021 pp | 0.00% 0.000 pp | USD32.53 +26.8% | 7 qtrs — |
| 42 | ESSEX INVESTMENT MANAGEMENT CO LLC | 251.0K +3.7K (+1.5%) | 10.35M +750.0K (+7.8%) | 0.34% +0.004 pp | 1.58% +0.109 pp | USD24.65 +67.3% | 7 qtrs — |
| 43 | JANE STREET GROUP, LLC | 242.4K -219.0K (-47.5%) | 10.00M -7.9M (-44.2%) | 0.33% -0.299 pp | 0.00% -0.001 pp | USD26.91 +53.3% | 7 qtrs — |
| 44 | BANK OF AMERICA CORP /DE/ | 229.4K -266.1K (-53.7%) | 9.46M -9.8M (-50.8%) | 0.31% -0.363 pp | 0.00% -0.001 pp | USD28.23 +46.1% | 7 qtrs — |
| 45 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 228.9K -69.4K (-23.3%) | 9.44M -2.1M (-18.5%) | 0.31% -0.095 pp | 0.03% -0.006 pp | USD26.96 +53.0% | 7 qtrs — |
| 46 | TREXQUANT INVESTMENT LP | 225.1K -134.7K (-37.4%) | 9.29M -4.7M (-33.5%) | 0.31% -0.184 pp | 0.08% -0.061 pp | USD24.10 +71.2% | 7 qtrs — |
| 47 | HILLSDALE INVESTMENT MANAGEMENT INC. | 224.1K -1.3K (-0.6%) | 9.24M +491.8K (+5.6%) | 0.30% -0.003 pp | 0.26% -0.009 pp | USD28.90 +42.7% | 3 qtrs — |
| 48 | SEI INVESTMENTS CO | 217.5K +46.3K (+27.1%) | 8.97M +2.3M (+35.0%) | 0.30% +0.062 pp | 0.01% +0.002 pp | USD31.59 +30.6% | 7 qtrs — |
| 49 | PEREGRINE CAPITAL MANAGEMENT LLC | 210.9K -3.5K (-1.6%) | 8.70M +376.3K (+4.5%) | 0.29% -0.005 pp | 0.27% +0.016 pp | USD18.92 +118.0% | 7 qtrs — |
| 50 | TWO SIGMA ADVISERS, LP | 208.3K +31.2K (+17.6%) | 8.59M +1.7M (+24.9%) | 0.28% +0.042 pp | 0.02% +0.003 pp | USD34.62 +19.2% | 3 qtrs — |
| 51 | CASTLEARK MANAGEMENT LLC | 192.2K +33.6K (+21.2%) | 7.93M +1.8M (+28.7%) | 0.26% +0.045 pp | 0.23% +0.060 pp | USD39.25 +5.1% | 2 qtrs — |
| 52 | ORBIMED ADVISORS LLC | 187.2K +187.2K (+100.0%) | 7.72M +7.7M (+100.0%) | 0.25% +0.254 pp | 0.16% +0.158 pp | USD41.25 +0.0% | 1 qtrs NEW |
| 53 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 173.4K +— (+0.0%) | 7.15M +419.7K (+6.2%) | 0.24% -0.001 pp | 0.01% 0.000 pp | USD38.83 +6.2% | 2 qtrs — |
| 54 | JANUS HENDERSON GROUP PLC | 153.4K +141.2K (+1,159.8%) | 6.33M +5.9M (+1,236.3%) | 0.21% +0.192 pp | 0.00% +0.003 pp | USD39.40 +4.7% | 7 qtrs — |
| 55 | VOLEON CAPITAL MANAGEMENT LP | 151.3K +62.1K (+69.7%) | 6.24M +2.8M (+80.2%) | 0.21% +0.084 pp | 0.13% +0.050 pp | USD39.82 +3.6% | 2 qtrs — |
| 56 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 148.8K +27.4K (+22.5%) | 6.14M +1.4M (+30.2%) | 0.20% +0.037 pp | 0.01% +0.002 pp | USD34.21 +20.6% | 3 qtrs — |
| 57 | WALLEYE CAPITAL LLC | 143.3K -269.8K (-65.3%) | 5.91M -10.1M (-63.1%) | 0.19% -0.368 pp | 0.02% -0.042 pp | USD34.45 +19.7% | 4 qtrs — |
| 58 | LAZARD ASSET MANAGEMENT LLC | 140.3K +2.0K (+1.4%) | 5.79M +416.8K (+7.8%) | 0.19% +0.002 pp | 0.01% +0.003 pp | USD37.50 +10.0% | 5 qtrs — |
| 59 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 126.4K +149.0 (+0.1%) | 5.21M +311.7K (+6.4%) | 0.17% 0.000 pp | 0.04% +0.003 pp | USD38.83 +6.2% | 2 qtrs — |
| 60 | LINDEN THOMAS ADVISORY SERVICES, LLC | 114.5K -1.6K (-1.4%) | 4.72M +215.7K (+4.8%) | 0.16% -0.003 pp | 0.48% +0.023 pp | USD18.00 +129.2% | 7 qtrs — |
| 61 | NORDEA INVESTMENT MANAGEMENT AB | 110.7K -20.4K (-15.6%) | 4.54M -477.1K (-9.5%) | 0.15% -0.028 pp | 0.00% -0.001 pp | USD24.91 +65.6% | 6 qtrs — |
| 62 | PDT PARTNERS, LLC | 101.6K +— (+0.0%) | 4.19M +245.9K (+6.2%) | 0.14% 0.000 pp | 0.27% +0.023 pp | USD25.46 +62.0% | 6 qtrs — |
| 63 | EAM INVESTORS, LLC | 96.0K -1.9K (-2.0%) | 3.96M +218.9K (+5.8%) | 0.13% -0.003 pp | 0.44% +0.012 pp | USD27.67 +49.1% | 3 qtrs — |
| 64 | ATIKA CAPITAL MANAGEMENT LLC | 94.0K +94.0K (+100.0%) | 3.88M +3.9M (+100.0%) | 0.13% +0.128 pp | 0.41% +0.408 pp | USD41.25 +0.0% | 1 qtrs NEW |
| 65 | GLOBEFLEX CAPITAL L P | 93.4K +— (+0.0%) | 3.85M +226.0K (+6.2%) | 0.13% 0.000 pp | 0.59% +0.031 pp | USD21.81 +89.1% | 7 qtrs — |
| 66 | JUMP FINANCIAL, LLC | 91.4K -21.5K (-19.0%) | 3.77M -613.8K (-14.0%) | 0.12% -0.030 pp | 0.05% -0.006 pp | USD27.67 +49.1% | 7 qtrs — |
| 67 | SQUAREPOINT OPS LLC | 85.2K -16.0 (0.0%) | 3.51M +205.5K (+6.2%) | 0.12% 0.000 pp | 0.00% +0.000 pp | USD25.61 +61.1% | 7 qtrs — |
| 68 | HENNION & WALSH ASSET MANAGEMENT, INC. | 79.2K -42.6K (-35.0%) | 3.27M -1.5M (-30.9%) | 0.11% -0.058 pp | 0.11% -0.059 pp | USD18.52 +122.7% | 7 qtrs — |
| 69 | UBS GROUP AG | 77.9K +28.1K (+56.4%) | 3.21M +1.3M (+66.2%) | 0.11% +0.038 pp | 0.00% +0.000 pp | USD33.95 +21.5% | 6 qtrs — |
| 70 | STATE STREET CORP | 73.0K -2.0K (-2.7%) | 3.01M +97.1K (+3.3%) | 0.10% -0.003 pp | 0.00% +0.000 pp | USD18.65 +121.2% | 7 qtrs — |
| 71 | GSA CAPITAL PARTNERS LLP | 69.0K -9.0K (-11.5%) | 2.85M -182.0K (-6.0%) | 0.09% -0.013 pp | 0.25% -0.007 pp | USD35.91 +14.9% | 3 qtrs — |
| 72 | SWISS NATIONAL BANK | 68.6K +2.9K (+4.4%) | 2.83M +278.6K (+10.9%) | 0.09% +0.004 pp | 0.00% +0.000 pp | USD19.32 +113.5% | 7 qtrs — |
| 73 | SCHONFELD STRATEGIC ADVISORS LLC | 64.0K -19.9K (-23.7%) | 2.64M -617.3K (-19.0%) | 0.09% -0.027 pp | 0.01% -0.007 pp | USD25.04 +64.7% | 7 qtrs — |
| 74 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 63.5K -1.6K (-2.4%) | 2.62M +92.3K (+3.7%) | 0.09% -0.002 pp | 0.00% +0.000 pp | USD19.44 +112.2% | 7 qtrs — |
| 75 | LEGATO CAPITAL MANAGEMENT LLC | 63.1K +5.5K (+9.5%) | 2.60M +366.2K (+16.4%) | 0.09% +0.007 pp | 0.22% -0.020 pp | USD22.35 +84.6% | 7 qtrs — |
| 76 | NORTHERN TRUST CORP | 60.3K +7.9K (+15.1%) | 2.49M +452.3K (+22.2%) | 0.08% +0.011 pp | 0.00% +0.000 pp | USD21.29 +93.8% | 7 qtrs — |
| 77 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 60.1K +— (+0.0%) | 2.48M +145.5K (+6.2%) | 0.08% 0.000 pp | 0.08% -0.007 pp | USD22.21 +85.7% | 4 qtrs — |
| 78 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 58.7K -1.7K (-2.7%) | 2.42M +77.9K (+3.3%) | 0.08% -0.002 pp | 0.00% +0.000 pp | USD37.14 +11.1% | 3 qtrs — |
| 79 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 55.6K -35.2K (-38.8%) | 2.29M -1.2M (-35.0%) | 0.08% -0.048 pp | 0.00% 0.000 pp | USD38.83 +6.2% | 2 qtrs — |
| 80 | WELLS FARGO & COMPANY/MN | 54.4K +46.7K (+609.4%) | 2.24M +1.9M (+653.6%) | 0.07% +0.064 pp | 0.00% +0.000 pp | USD39.01 +5.7% | 7 qtrs — |
| 81 | RAYMOND JAMES FINANCIAL INC | 49.2K -29.9K (-37.8%) | 2.02M -1.1M (-34.3%) | 0.07% -0.041 pp | 0.00% 0.000 pp | USD19.78 +108.5% | 5 qtrs — |
| 82 | SUMMITTX CAPITAL, L.P. | 48.8K +48.8K (+100.0%) | 2.01M +2.0M (+100.0%) | 0.07% +0.066 pp | 0.06% +0.061 pp | USD41.25 +0.0% | 3 qtrs — |
| 83 | JPMORGAN CHASE & CO | 48.4K -144.1K (-74.9%) | 2.00M -5.5M (-73.3%) | 0.07% -0.196 pp | 0.00% 0.000 pp | USD27.53 +49.8% | 6 qtrs — |
| 84 | IEQ CAPITAL, LLC | 47.8K +1.9K (+4.0%) | 1.97M +187.8K (+10.5%) | 0.07% +0.002 pp | 0.01% +0.001 pp | USD23.32 +76.9% | 4 qtrs — |
| 85 | GEODE CAPITAL MANAGEMENT, LLC | 45.8K +221.0 (+0.5%) | 1.89M +119.3K (+6.8%) | 0.06% +0.000 pp | 0.00% +0.000 pp | USD18.25 +126.0% | 7 qtrs — |
| 86 | CERITY PARTNERS LLC | 43.2K +183.0 (+0.4%) | 1.78M +111.7K (+6.7%) | 0.06% +0.000 pp | 0.00% 0.000 pp | USD24.72 +66.9% | 6 qtrs — |
| 87 | AMI ASSET MANAGEMENT CORP | 43.1K +9.0 (+0.0%) | 1.78M +104.7K (+6.3%) | 0.06% 0.000 pp | 0.10% +0.007 pp | USD24.03 +71.7% | 6 qtrs — |
| 88 | UBS ASSET MANAGEMENT AMERICAS INC | 42.4K -13.1K (-23.6%) | 1.75M -406.7K (-18.9%) | 0.06% -0.018 pp | 0.00% 0.000 pp | USD25.62 +61.0% | 6 qtrs — |
| 89 | BAIRD FINANCIAL GROUP, INC. | 42.2K -13.1K (-23.6%) | 1.74M -405.5K (-18.9%) | 0.06% -0.018 pp | 0.00% -0.001 pp | USD27.67 +49.1% | 3 qtrs — |
| 90 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 40.4K +40.4K (+100.0%) | 1.66M +1.7M (+100.0%) | 0.05% +0.055 pp | 0.00% +0.001 pp | USD41.25 +0.0% | 1 qtrs NEW |
| 91 | ENGINEERS GATE MANAGER LP | 39.9K -47.6K (-54.4%) | 1.64M -1.8M (-51.6%) | 0.05% -0.065 pp | 0.02% -0.019 pp | USD31.27 +31.9% | 3 qtrs — |
| 92 | MAN GROUP PLC | 39.4K -28.5K (-41.9%) | 1.63M -1.0M (-38.3%) | 0.05% -0.039 pp | 0.00% -0.002 pp | USD38.83 +6.2% | 6 qtrs — |
| 93 | Y-INTERCEPT (HONG KONG) LTD | 35.9K +29.5K (+461.2%) | 1.48M +1.2M (+496.2%) | 0.05% +0.040 pp | 0.03% +0.027 pp | USD38.83 +6.2% | 7 qtrs — |
| 94 | INVESCO LTD. | 32.3K +6.7K (+25.9%) | 1.33M +336.7K (+33.8%) | 0.04% +0.009 pp | 0.00% +0.000 pp | USD29.63 +39.2% | 6 qtrs — |
| 95 | AMERIPRISE FINANCIAL INC | 32.1K -1.4K (-4.3%) | 1.32M +22.2K (+1.7%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD25.52 +61.6% | 6 qtrs — |
| 96 | JAIN GLOBAL LLC | 31.8K +10.9K (+52.0%) | 1.31M +499.4K (+61.5%) | 0.04% +0.015 pp | 0.01% +0.003 pp | USD32.31 +27.7% | 3 qtrs — |
| 97 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 31.5K +— (+0.0%) | 1.30M +76.2K (+6.2%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD18.00 +129.2% | 7 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 92 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Innovator IBD 50 ETF FFTY | 2.93% | 2.62M | 0.80% |
| 2 | abrdn Focused U.S. Small Cap Active ETF AFSC | 2.71% | 271.8K | 1.09% |
| 3 | Fidelity Disruptive Medicine ETF FMED | 1.60% | 743.5K | 0.50% |
| 4 | Virtus Biotech ETF BBP | 1.58% | 1.55M | 0.34% |
| 5 | First Trust Active Factor Small Cap ETF AFSM | 0.56% | 631.8K | 0.75% |
| 6 | American Century Small Cap Growth Insights ETF ACSG | 0.51% | 128.8K | 0.49% |
| 7 | Hartford Multifactor Small Cap ETF ROSC | 0.38% | 230.9K | 0.34% |
| 8 | iShares MSCI USA Small-Cap Min Vol Factor ETF SMMV | 0.35% | 1.00M | 0.20% |
| 9 | Franklin Genomic Advancements ETF HELX | 0.33% | 100.5K | 0.50% |
| 10 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.33% | 3.75M | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.68
Neutral
Ratio by volume
0.89
Neutral
Buys
38
Sells
56
Shares acquired
1.12M
Shares disposed
1.27M
Cash buys
—
Cash sales
12.00
Net activity
-145,222
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 48,565 | 30.93 | 1.50M | 48,565 | D | ↗ |
| 2026-05-01 | Paolini John F. | Officer | M-Exempt | A | Class A Ordinary Share | 58,424 | 10.36 | 605.3K | 124,047 | D | ↗ |
| 2026-04-30 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 2,141 | 30.93 | 66.2K | 48,565 | D | ↗ |
| 2026-04-29 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 22,544 | 30.93 | 697.3K | 50,706 | D | ↗ |
| 2026-04-28 | Quart Barry D | Director | S-Sale | D | Class A Ordinary Share | 13,099 | 50.10 | 656.3K | 12,546 | D | ↗ |
| 2026-04-28 | Patel Sanj K | Director / Officer | S-Sale | D | Class A Ordinary Share | 74,635 | 50.43 | 3.76M | 409,019 | D | ↗ |
| 2026-04-09 | Moat Ross | Officer | S-Sale | D | Class A Ordinary Share | 1,703 | 46.69 | 79.5K | 12,029 | D | ↗ |
| 2026-04-09 | Megna Michael R | Officer | S-Sale | D | Class A Ordinary Share | 6,625 | 46.69 | 309.3K | 27,418 | D | ↗ |
| 2026-04-07 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 2,726 | 0.00 | — | 23,976 | D | ↗ |
| 2026-04-07 | Ragosa Mark | Officer | M-Exempt | D | Restricted Share Unit | 2,694 | 0.00 | — | 0 | D | ↗ |
| 2026-04-07 | Patel Sanj K | Director / Officer | M-Exempt | D | Restricted Share Unit | 9,991 | 0.00 | — | 0 | D | ↗ |
| 2026-04-07 | Paolini John F. | Officer | M-Exempt | A | Class A Ordinary Share | 2,497 | 0.00 | — | 66,831 | D | ↗ |
| 2026-04-07 | Moat Ross | Officer | M-Exempt | D | Restricted Share Unit | 2,477 | 0.00 | — | 0 | D | ↗ |
| 2026-04-07 | Megna Michael R | Officer | M-Exempt | D | Restricted Share Unit | 3,932 | 0.00 | — | 0 | D | ↗ |
| 2026-04-06 | Quart Barry D | Director | S-Sale | D | Class A Ordinary Share | 6,901 | 50.00 | 345.1K | 12,546 | D | ↗ |
| 2026-04-06 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 7,278 | 10.36 | 75.4K | 7,278 | D | ↗ |
| 2026-04-06 | Moat Ross | Officer | S-Sale | D | Class A Ordinary Share | 2,367 | 48.58 | 115.0K | 12,029 | D | ↗ |
| 2026-04-01 | Tessari Eben | Officer | A-Award | A | Share Option | 33,200 | 48.13 | 1.60M | 33,200 | D | ↗ |
| 2026-04-01 | Ragosa Mark | Officer | F-InKind | D | Class A Ordinary Share | 2,510 | 48.13 | 120.8K | 14,763 | D | ↗ |
| 2026-04-01 | Patel Sanj K | Director / Officer | M-Exempt | D | Restricted Share Unit | 6,481 | 0.00 | — | 6,481 | D | ↗ |
| 2026-04-01 | Paolini John F. | Officer | A-Award | A | Share Option | 26,750 | 48.13 | 1.29M | 26,750 | D | ↗ |
| 2026-04-01 | Moat Ross | Officer | A-Award | A | Restricted Share Unit | 9,250 | 0.00 | — | 9,250 | D | ↗ |
| 2026-04-01 | Megna Michael R | Officer | A-Award | A | Performance Share Unit | 7,300 | 0.00 | — | 7,300 | D | ↗ |
| 2026-03-09 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 2,036 | 22.89 | 46.6K | 0 | D | ↗ |
| 2026-03-02 | Paolini John F. | Officer | M-Exempt | A | Class A Ordinary Share | 40,000 | 10.36 | 414.4K | 101,324 | D | ↗ |
| 2026-02-12 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 2,690 | 15.47 | 41.6K | 15,236 | D | ↗ |
| 2026-02-10 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 110 | 15.47 | 1.7K | 12,656 | D | ↗ |
| 2026-02-09 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 8,374 | 12.97 | 108.6K | 0 | D | ↗ |
| 2026-02-04 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 2,602 | 15.47 | 40.3K | 15,148 | D | ↗ |
| 2026-02-03 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 12,528 | 15.47 | 193.8K | 25,074 | D | ↗ |
| 2026-02-02 | Quart Barry D | Director | M-Exempt | D | Share Option | 830 | 15.47 | 12.8K | 17,930 | D | ↗ |
| 2026-02-01 | Levy Richard S | Director | M-Exempt | A | Class A Ordinary Share | 683 | 0.00 | — | 19,157 | D | ↗ |
| 2026-01-15 | Tessari Eben | Officer | A-Award | A | Class A Ordinary Share | 365 | 24.16 | 8.8K | 17,031 | D | ↗ |
| 2026-01-15 | Moat Ross | Officer | A-Award | A | Class A Ordinary Share | 879 | 24.16 | 21.2K | 10,294 | D | ↗ |
| 2026-01-15 | Megna Michael R | Officer | A-Award | A | Class A Ordinary Share | 372 | 24.16 | 9.0K | 27,418 | D | ↗ |
| 2026-01-08 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 12,000 | 41.89 | 502.7K | 19,086 | D | ↗ |
| 2025-12-15 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 6,000 | 8.83 | 53.0K | 28,714 | D | ↗ |
| 2025-12-15 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 20,129 | 10.36 | 208.5K | 32,675 | D | ↗ |
| 2025-12-08 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 42,841 | 41.49 | 1.78M | 31,086 | D | ↗ |
| 2025-11-26 | Tessari Eben | Officer | M-Exempt | D | Share Option | 200 | 22.89 | 4.6K | 46,938 | D | ↗ |
| 2025-11-17 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 645 | 40.08 | 25.9K | 34,539 | D | ↗ |
| 2025-11-13 | Patel Sanj K | Director / Officer | G-Gift | A | Class A Ordinary Share | 60,000 | 0.00 | — | 60,000 | I | ↗ |
| 2025-11-12 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 19,900 | 30.93 | 615.5K | 50,986 | D | ↗ |
| 2025-11-12 | Patel Sanj K | Director / Officer | G-Gift | A | Class A Ordinary Share | 111,794 | 0.00 | — | 111,794 | I | ↗ |
| 2025-10-31 | Paolini John F. | Officer | S-Sale | D | Class A Ordinary Share | 82,542 | 37.14 | 3.07M | 61,324 | D | ↗ |
| 2025-10-28 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 100 | 30.93 | 3.1K | 31,186 | D | ↗ |
| 2025-10-22 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 97,390 | 3.80 | 370.1K | 209,184 | D | ↗ |
| 2025-10-21 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 39,331 | 3.80 | 149.5K | 97,390 | D | ↗ |
| 2025-10-20 | Patel Sanj K | Director / Officer | S-Sale | D | Class A Ordinary Share | 22,314 | 39.32 | 877.4K | 111,794 | D | ↗ |
| 2025-10-20 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 791 | 15.50 | 12.3K | 38,892 | D | ↗ |
| 2025-10-14 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 6,500 | 8.83 | 57.4K | 41,052 | D | ↗ |
| 2025-10-04 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 175 | 0.00 | — | 38,186 | D | ↗ |
| 2025-09-29 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 42,000 | 38.33 | 1.61M | 34,552 | D | ↗ |
| 2025-09-15 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 6,500 | 8.83 | 57.4K | 50,952 | D | ↗ |
| 2025-09-05 | Tessari Eben | Officer | M-Exempt | D | Share Option | 13,389 | 15.52 | 207.8K | 0 | D | ↗ |
| 2025-09-04 | Tessari Eben | Officer | M-Exempt | D | Share Option | 46,546 | 15.52 | 722.4K | 13,389 | D | ↗ |
| 2025-09-04 | Moat Ross | Officer | S-Sale | D | Class A Ordinary Share | 3,523 | 35.31 | 124.4K | 9,415 | D | ↗ |
| 2025-09-03 | Tessari Eben | Officer | M-Exempt | D | Share Option | 15,026 | 15.50 | 232.9K | 44,974 | D | ↗ |
| 2025-09-03 | Megna Michael R | Officer | S-Sale | D | Class A Ordinary Share | 11,000 | 34.84 | 383.2K | 38,011 | D | ↗ |
| 2025-09-02 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 1,964 | 0.00 | — | 45,402 | D | ↗ |
| 2025-09-02 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 1,861 | 0.00 | — | 31,986 | D | ↗ |
| 2025-09-02 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 6,569 | 0.00 | — | 114,971 | D | ↗ |
| 2025-09-02 | Paolini John F. | Officer | M-Exempt | A | Class A Ordinary Share | 1,725 | 0.00 | — | 62,159 | D | ↗ |
| 2025-09-02 | Moat Ross | Officer | M-Exempt | D | Restricted Share Unit | 994 | 0.00 | — | 0 | D | ↗ |
| 2025-09-02 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 774 | 0.00 | — | 38,386 | D | ↗ |
| 2025-09-01 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 2,726 | 0.00 | — | 46,460 | D | ↗ |
| 2025-09-01 | Ragosa Mark | Officer | A-Award | A | Share Option | 39,363 | 33.49 | 1.32M | 39,363 | D | ↗ |
| 2025-09-01 | Patel Sanj K | Director / Officer | M-Exempt | D | Restricted Share Unit | 6,238 | 0.00 | — | 18,712 | D | ↗ |
| 2025-09-01 | Paolini John F. | Officer | A-Award | A | Restricted Share Unit | 9,828 | 0.00 | — | 9,828 | D | ↗ |
| 2025-09-01 | Moat Ross | Officer | A-Award | A | Share Option | 39,364 | 33.49 | 1.32M | 39,364 | D | ↗ |
| 2025-09-01 | Megna Michael R | Officer | A-Award | A | Share Option | 21,150 | 33.49 | 708.3K | 21,150 | D | ↗ |
| 2025-08-18 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 16,100 | 33.77 | 543.7K | 40,315 | D | ↗ |
| 2025-08-14 | Malley Thomas | Director | M-Exempt | A | Class A Ordinary Shares | 18,760 | 15.47 | 290.2K | 31,306 | D | ↗ |
| 2025-08-13 | Malley Thomas | Director | M-Exempt | A | Class A Ordinary Shares | 30,000 | 9.88 | 296.4K | 62,675 | D | ↗ |
| 2025-08-12 | Malley Thomas | Director | M-Exempt | A | Class A Ordinary Shares | 21,959 | 1.86 | 40.8K | 34,505 | D | ↗ |
| 2025-08-06 | Paolini John F. | Officer | S-Sale | D | Class A Ordinary Share | 29,325 | 32.55 | 954.5K | 57,403 | D | ↗ |
| 2025-08-05 | Tessari Eben | Officer | M-Exempt | D | Share Option | 30,444 | 12.97 | 394.9K | 16,694 | D | ↗ |
| 2025-08-04 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 18,889 | 22.89 | 432.4K | 2,036 | D | ↗ |
| 2025-08-04 | Megna Michael R | Officer | S-Sale | D | Class A Ordinary Share | 17,000 | 32.35 | 550.0K | 33,041 | D | ↗ |
| 2025-07-30 | Popovits Kimberly J | Director | M-Exempt | A | Class A Ordinary Share | 45,748 | 10.36 | 473.9K | 58,294 | D | ↗ |
| 2025-07-15 | Tessari Eben | Officer | A-Award | A | Class A Ordinary Share | 752 | 15.63 | 11.8K | 49,915 | D | ↗ |
| 2025-07-15 | Megna Michael R | Officer | A-Award | A | Class A Ordinary Share | 495 | 15.63 | 7.7K | 33,041 | D | ↗ |
| 2025-07-14 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 6,500 | 8.83 | 57.4K | 68,063 | D | ↗ |
| 2025-07-01 | Levy Richard S | Director | M-Exempt | A | Class A Ordinary Share | 1,101 | 0.00 | — | 18,474 | D | ↗ |
| 2025-06-16 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 17,300 | 28.28 | 489.2K | 61,563 | D | ↗ |
| 2025-06-11 | Tessari Eben | Officer | M-Exempt | D | Share Option | 45,042 | 10.36 | 466.6K | 38,928 | D | ↗ |
| 2025-06-11 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 12,336 | 3.80 | 46.9K | 24,882 | D | ↗ |
| 2025-06-10 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 15,506 | 30.46 | 472.3K | 72,363 | D | ↗ |
| 2025-06-10 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 8,212 | 3.80 | 31.2K | 20,758 | D | ↗ |
| 2025-06-09 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 10,319 | 10.36 | 106.9K | 82,682 | D | ↗ |
| 2025-06-09 | Quart Barry D | Director | M-Exempt | A | Class A Ordinary Share | 6,900 | 3.80 | 26.2K | 19,446 | D | ↗ |
| 2025-06-05 | Quart Barry D | Director | M-Exempt | D | Restricted Share Units | 3,173 | 0.00 | — | 0 | D | ↗ |
| 2025-06-05 | Popovits Kimberly J | Director | M-Exempt | D | Restricted Share Units | 3,173 | 0.00 | — | 0 | D | ↗ |
| 2025-06-05 | McCain Tracey L | Director | M-Exempt | A | Class A Ordinary Share | 3,173 | 0.00 | — | 12,546 | D | ↗ |
| 2025-06-05 | Malley Thomas | Director | M-Exempt | D | Restricted Share Units | 3,173 | 0.00 | — | 0 | D | ↗ |
| 2025-06-05 | Levy Richard S | Director | M-Exempt | D | Restricted Share Units | 3,173 | 0.00 | — | 0 | D | ↗ |
| 2025-06-05 | Cole G Bradley | Director | M-Exempt | D | Restricted Share Units | 3,173 | 0.00 | — | 0 | D | ↗ |
| 2025-06-03 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 18,299 | 18.00 | 329.4K | 45,308 | D | ↗ |
| 2025-06-03 | Quart Barry D | Director | A-Award | A | Restricted Share Units | 2,799 | 0.00 | — | 2,799 | D | ↗ |
| 2025-06-03 | Popovits Kimberly J | Director | A-Award | A | Restricted Share Units | 2,799 | 0.00 | — | 2,799 | D | ↗ |
| 2025-06-03 | Moat Ross | Officer | M-Exempt | A | Class A Ordinary Share | 27,594 | 13.35 | 368.4K | 37,009 | D | ↗ |
| 2025-06-03 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 15,211 | 15.50 | 235.8K | 47,757 | D | ↗ |
| 2025-06-03 | McCain Tracey L | Director | A-Award | A | Share Option | 16,798 | 29.11 | 489.0K | 16,798 | D | ↗ |
| 2025-06-03 | Malley Thomas | Director | A-Award | A | Restricted Share Units | 2,799 | 0.00 | — | 2,799 | D | ↗ |
| 2025-06-03 | Levy Richard S | Director | A-Award | A | Share Option | 16,798 | 29.11 | 489.0K | 16,798 | D | ↗ |
| 2025-06-03 | Cole G Bradley | Director | A-Award | A | Restricted Share Units | 2,799 | 0.00 | — | 2,799 | D | ↗ |
| 2025-06-03 | BAKER BROS. ADVISORS LP | Director | A-Award | A | Class A Ordinary Shares | 8,397 | 0.00 | — | 137,199 | I | ↗ |
| 2025-05-28 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 62,116 | 1.59 | 98.8K | 0 | D | ↗ |
| 2025-05-27 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 19,317 | 1.59 | 30.7K | 115,991 | D | ↗ |
| 2025-05-23 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 4,837 | 1.59 | 7.7K | 81,433 | D | ↗ |
| 2025-05-20 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 2,349 | 1.59 | 3.7K | 99,023 | D | ↗ |
| 2025-05-19 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 12,000 | 26.41 | 316.9K | 72,363 | D | ↗ |
| 2025-05-13 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 2,872 | 1.59 | 4.6K | 99,546 | D | ↗ |
| 2025-05-09 | Patel Sanj K | Director / Officer | M-Exempt | A | Class A Ordinary Share | 6,029 | 1.59 | 9.6K | 102,703 | D | ↗ |
| 2025-05-08 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 101 | 1.59 | 160.59 | 97,520 | D | ↗ |
| 2025-05-07 | Patel Sanj K | Director / Officer | M-Exempt | D | Share Option | 1,965 | 1.59 | 3.1K | 97,621 | D | ↗ |
| 2025-05-07 | Paolini John F. | Officer | S-Sale | D | Class A Ordinary Share | 200 | 27.00 | 5.4K | 57,403 | D | ↗ |
| 2025-05-07 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 14,420 | 11.97 | 172.6K | 50,193 | D | ↗ |
| 2025-05-05 | Moat Ross | Officer | M-Exempt | A | Class A Ordinary Share | 6,272 | 17.76 | 111.4K | 15,687 | D | ↗ |
| 2025-05-02 | Moat Ross | Officer | M-Exempt | A | Class A Ordinary Share | 3,850 | 17.76 | 68.4K | 13,265 | D | ↗ |
| 2025-05-01 | Tessari Eben | Officer | A-Award | A | Performance Share Option | 8,042 | 27.74 | 223.1K | 8,042 | D | ↗ |
| 2025-05-01 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 12,000 | 17.92 | 215.0K | 39,009 | D | ↗ |
| 2025-05-01 | Patel Sanj K | Director / Officer | A-Award | A | Performance Share Unit | 8,386 | 0.00 | — | 8,386 | D | ↗ |
| 2025-05-01 | Paolini John F. | Officer | A-Award | A | Performance Share Option | 8,007 | 27.74 | 222.1K | 8,007 | D | ↗ |
| 2025-05-01 | Moat Ross | Officer | M-Exempt | D | Share Option | 13,406 | 13.35 | 179.0K | 27,594 | D | ↗ |
| 2025-05-01 | Megna Michael R | Officer | A-Award | A | Performance Share Unit | 3,433 | 0.00 | — | 3,433 | D | ↗ |
| 2025-04-30 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 21,254 | 16.90 | 359.2K | 2,471 | D | ↗ |
| 2025-04-29 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 22,000 | 15.50 | 341.0K | 0 | D | ↗ |
| 2025-04-29 | Moat Ross | Officer | M-Exempt | D | Share Option | 6,296 | 12.97 | 81.7K | 1,658 | D | ↗ |
| 2025-04-26 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 990 | 0.00 | — | 27,488 | D | ↗ |
| 2025-04-21 | Moat Ross | Officer | S-Sale | D | Class A Ordinary Share | 18,259 | 20.29 | 370.5K | 9,415 | D | ↗ |
| 2025-04-14 | Tessari Eben | Officer | M-Exempt | D | Share Option | 7,000 | 3.80 | 26.6K | 7,049 | D | ↗ |
| 2025-04-07 | Tessari Eben | Officer | M-Exempt | D | Restricted Share Unit | 2,726 | 0.00 | — | 2,726 | D | ↗ |
| 2025-04-07 | Ragosa Mark | Officer | M-Exempt | D | Restricted Share Unit | 2,694 | 0.00 | — | 2,694 | D | ↗ |
| 2025-04-07 | Patel Sanj K | Director / Officer | M-Exempt | D | Restricted Share Unit | 9,992 | 0.00 | — | 9,991 | D | ↗ |
| 2025-04-07 | Paolini John F. | Officer | M-Exempt | D | Restricted Share Unit | 2,498 | 0.00 | — | 2,497 | D | ↗ |
| 2025-04-07 | Moat Ross | Officer | M-Exempt | D | Restricted Share Unit | 2,477 | 0.00 | — | 2,477 | D | ↗ |
| 2025-04-07 | Megna Michael R | Officer | M-Exempt | D | Restricted Share Unit | 3,933 | 0.00 | — | 3,932 | D | ↗ |
| 2025-04-01 | Tessari Eben | Officer | A-Award | A | Restricted Share Unit | 9,828 | 0.00 | — | 9,828 | D | ↗ |
| 2025-04-01 | Ragosa Mark | Officer | M-Exempt | D | Restricted Share Unit | 1,750 | 0.00 | — | 3,500 | D | ↗ |
| 2025-04-01 | Patel Sanj K | Director / Officer | F-InKind | D | Class A Ordinary Share | 2,304 | 21.77 | 50.2K | 94,531 | D | ↗ |
| 2025-04-01 | Paolini John F. | Officer | M-Exempt | A | Class A Ordinary Share | 1,624 | 0.00 | — | 54,880 | D | ↗ |
| 2025-04-01 | Moat Ross | Officer | A-Award | A | Share Option | 39,364 | 21.77 | 857.0K | 39,364 | D | ↗ |
| 2025-04-01 | Megna Michael R | Officer | A-Award | A | Restricted Share Unit | 10,575 | 0.00 | — | 10,575 | D | ↗ |
| 2025-03-20 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 15,944 | 12.97 | 206.8K | 39,326 | D | ↗ |
| 2025-03-19 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 8,879 | 23.10 | 205.1K | 23,382 | D | ↗ |
| 2025-03-17 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 11,464 | 12.97 | 148.7K | 33,197 | D | ↗ |
| 2025-03-16 | Tessari Eben | Officer | F-InKind | D | Class A Ordinary Share | 577 | 22.61 | 13.0K | 77,953 | D | ↗ |
| 2025-03-16 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 872 | 0.00 | — | 23,830 | D | ↗ |
| 2025-03-16 | Patel Sanj K | Director / Officer | M-Exempt | D | Restricted Share Unit | 6,569 | 0.00 | — | 0 | D | ↗ |
| 2025-03-16 | Paolini John F. | Officer | M-Exempt | D | Restricted Share Unit | 1,725 | 0.00 | — | 0 | D | ↗ |
| 2025-03-16 | Moat Ross | Officer | M-Exempt | D | Restricted Share Unit | 994 | 0.00 | — | 0 | D | ↗ |
| 2025-03-16 | Megna Michael R | Officer | M-Exempt | D | Restricted Share Unit | 774 | 0.00 | — | 0 | D | ↗ |
| 2025-03-12 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 36,372 | 22.25 | 809.3K | 22,958 | D | ↗ |
| 2025-03-12 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 9,051 | 11.10 | 100.5K | 35,579 | D | ↗ |
| 2025-03-10 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 12,409 | 21.06 | 261.3K | 76,566 | D | ↗ |
| 2025-02-10 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 7,000 | 3.80 | 26.6K | 95,975 | D | ↗ |
| 2025-01-15 | Moat Ross | Officer | A-Award | A | Class A Ordinary Share | 1,118 | 16.00 | 17.9K | 22,854 | D | ↗ |
| 2025-01-15 | Megna Michael R | Officer | A-Award | A | Class A Ordinary Share | 469 | 16.00 | 7.5K | 26,997 | D | ↗ |
| 2025-01-13 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 7,000 | 3.80 | 26.6K | 102,975 | D | ↗ |
| 2024-12-16 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 16,017 | 1.59 | 25.5K | 118,992 | D | ↗ |
| 2024-12-09 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 18,860 | 21.38 | 403.2K | 22,958 | D | ↗ |
| 2024-12-06 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 8,969 | 21.27 | 190.8K | 22,958 | D | ↗ |
| 2024-12-05 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 1,123 | 10.76 | 12.1K | 24,081 | D | ↗ |
| 2024-12-04 | Ragosa Mark | Officer | M-Exempt | D | Share Option | 5,024 | 10.76 | 54.1K | 28,057 | D | ↗ |
| 2024-12-03 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 8,969 | 21.45 | 192.4K | 22,958 | D | ↗ |
| 2024-11-29 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 9 | 11.10 | 99.90 | 26,537 | D | ↗ |
| 2024-11-27 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 8,637 | 11.10 | 95.9K | 35,165 | D | ↗ |
| 2024-11-18 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 10,000 | 1.59 | 15.9K | 119,975 | D | ↗ |
| 2024-11-07 | Levy Richard S | Director | A-Award | A | Restricted Share Units | 1,303 | 0.00 | — | 1,303 | D | ↗ |
| 2024-11-06 | Patel Sanj K | Director / Officer | S-Sale | D | Class A Ordinary Share | 89,561 | 23.00 | 2.06M | 79,551 | D | ↗ |
| 2024-10-15 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 10,000 | 1.59 | 15.9K | 126,975 | D | ↗ |
| 2024-10-04 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 175 | 0.00 | — | 26,610 | D | ↗ |
| 2024-10-04 | Boyd Meta Cantey | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-04 | BAKER BROS. ADVISORS LP | Director | A-Award | A | Class A Ordinary Shares | 4,730 | 0.00 | — | 2,730,419 | I | ↗ |
| 2024-09-23 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 17,500 | 24.99 | 437.3K | 116,975 | D | ↗ |
| 2024-09-03 | Paolini John F. | Officer | M-Exempt | D | Share Option | 60,217 | 1.86 | 112.0K | 0 | — | ↗ |
| 2024-09-03 | Moat Ross | Officer | S-Sale | D | Class A Ordinary Share | 1,160 | 27.12 | 31.5K | 21,736 | — | ↗ |
| 2024-09-02 | Tessari Eben | Officer | M-Exempt | A | Class A Ordinary Share | 1,964 | 0.00 | — | 125,052 | — | ↗ |
| 2024-09-02 | Ragosa Mark | Officer | M-Exempt | A | Class A Ordinary Share | 1,861 | 0.00 | — | 23,914 | — | ↗ |
| 2024-09-02 | Patel Sanj K | Director / Officer | F-InKind | D | Class A Ordinary Share | 3,177 | 26.74 | 85.0K | 79,551 | — | ↗ |
| 2024-09-02 | Paolini John F. | Officer | M-Exempt | D | Restricted Share Unit | 1,725 | 0.00 | — | 1,725 | — | ↗ |
| 2024-09-02 | Moat Ross | Officer | F-InKind | D | Class A Ordinary Share | 345 | 26.74 | 9.2K | 21,736 | — | ↗ |
| 2024-09-02 | Megna Michael R | Officer | M-Exempt | A | Class A Ordinary Share | 775 | 0.00 | — | 26,764 | — | ↗ |
| 2024-09-01 | Tessari Eben | Officer | M-Exempt | D | Restricted Share Unit | 1,773 | 0.00 | — | 5,318 | — | ↗ |
| 2024-09-01 | Ragosa Mark | Officer | M-Exempt | D | Restricted Share Unit | 2,694 | 0.00 | — | 5,388 | — | ↗ |
| 2024-09-01 | Patel Sanj K | Director / Officer | M-Exempt | D | Restricted Share Unit | 6,482 | 0.00 | — | 19,443 | — | ↗ |
| 2024-09-01 | Paolini John F. | Officer | M-Exempt | D | Restricted Share Unit | 1,624 | 0.00 | — | 4,872 | — | ↗ |
| 2024-09-01 | Moat Ross | Officer | A-Award | A | Share Option | 36,100 | 26.74 | 965.3K | 36,100 | — | ↗ |
| 2024-09-01 | Megna Michael R | Officer | F-InKind | D | Class A Ordinary Share | 2,755 | 26.74 | 73.7K | 25,989 | — | ↗ |
| 2024-08-27 | Tessari Eben | Officer | S-Sale | D | Class A Ordinary Share | 17,500 | 26.91 | 470.9K | 119,911 | — | ↗ |
| 2024-07-23 | Ragosa Mark | Officer | S-Sale | D | Class A Ordinary Share | 24,248 | 24.79 | 601.1K | 19,253 | — | ↗ |
| 2024-07-23 | Patel Sanj K | Director / Officer | S-Sale | D | Class A Ordinary Share | 63,049 | 27.01 | 1.70M | 63,012 | — | ↗ |
| 2024-07-23 | Paolini John F. | Officer | M-Exempt | D | Share Option | 22,000 | 1.86 | 40.9K | 60,217 | — | ↗ |
| 2024-07-15 | Moat Ross | Officer | A-Award | A | Class A Ordinary Share | 211 | 15.65 | 3.3K | 18,391 | — | ↗ |
| 2024-07-15 | Megna Michael R | Officer | A-Award | A | Class A Ordinary Share | 480 | 15.65 | 7.5K | 22,254 | — | ↗ |
| 2024-06-06 | Quart Barry D | Director | M-Exempt | D | Restricted Share Units | 4,373 | 0.00 | — | 0 | — | ↗ |
| 2024-06-06 | Popovits Kimberly J | Director | M-Exempt | A | Class A Common Share | 4,373 | 0.00 | — | 9,373 | — | ↗ |
| 2024-06-06 | McCain Tracey L | Director | M-Exempt | D | Restricted Share Units | 4,373 | 0.00 | — | 0 | — | ↗ |
| 2024-06-06 | Malley Thomas | Director | M-Exempt | A | Class A Common Shares | 4,373 | 0.00 | — | 9,373 | — | ↗ |
Executive team
Top executives
EBIT / Employee
242.8K
Shares Outstanding
75.17M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 943.1K | — | 3.80M | 4.74M | 1.28M | 14.0K | 10.78M | 79.21% | ↗ |
| 2 | 2025 | Ross Moat Executive Vice President and Chief Commercial Officer | 586.3K | — | 1.08M | 1.36M | 533.3K | 77.8K | 3.64M | 67.09% | ↗ |
| 3 | 2025 | John F. Paolini, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 585.1K | — | 1.08M | 1.36M | 530.9K | 14.0K | 3.57M | 68.35% | ↗ |
| 4 | 2025 | Eben Tessari Executive Vice President and Chief Operating Officer | 586.5K | — | 1.08M | 1.36M | 533.3K | 5.9K | 3.57M | 68.44% | ↗ |
| 5 | 2025 | Mark Ragosa Senior Vice President and Chief Financial Officer | 552.8K | — | 978.1K | 1.22M | 516.7K | 14.0K | 3.28M | 67.00% | ↗ |
| 6 | 2024 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 899.4K | — | 1.56M | 3.81M | 730.7K | 13.8K | 7.01M | 76.55% | ↗ |
| 7 | 2024 | Ross Moat Executive Vice President and Chief Commercial Officer | 511.6K | — | 434.8K | 1.06M | 287.8K | 297.1K | 2.59M | 57.67% | ↗ |
| 8 | 2024 | John F. Paolini, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 563.2K | — | 437.2K | 1.07M | 316.8K | 13.8K | 2.40M | 62.72% | ↗ |
| 9 | 2024 | Eben Tessari Executive Vice President and Chief Operating Officer | 520.6K | — | 436.0K | 1.07M | 292.8K | 5.2K | 2.32M | 64.71% | ↗ |
| 10 | 2024 | Mark Ragosa Senior Vice President and Chief Financial Officer | 503.7K | — | 397.5K | 972.6K | 283.3K | 13.8K | 2.17M | 63.11% | ↗ |
| 11 | 2023 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 864.8K | — | 739.4K | 2.98M | 695.7K | 13.2K | 5.30M | 70.30% | ↗ |
| 12 | 2023 | Sanj K. Patel Chief Executive Officer and Chairman of our Board of Directors | 864.2K | — | 739.4K | 2.98M | 695.7K | 13.2K | 5.30M | 70.30% | ↗ |
| 13 | 2023 | Eben Tessari Executive Vice President and Chief Operating Officer | 500.6K | — | 202.2K | 816.6K | 278.8K | 5.0K | 1.80M | 56.50% | ↗ |
| 14 | 2023 | John F. Paolini, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 541.5K | — | 185.3K | 748.1K | 301.6K | 13.2K | 1.79M | 52.15% | ↗ |
| 15 | 2023 | John F. Paolini, M.D. Senior Vice President and Chief Medical Officer | 541.0K | — | 185.3K | 748.1K | 301.6K | 13.2K | 1.79M | 52.17% | ↗ |
| 16 | 2023 | Mark Ragosa Senior Vice President and Chief Financial Officer | 479.7K | — | 199.6K | 807.1K | 267.1K | 13.2K | 1.77M | 56.98% | ↗ |
| 17 | 2023 | Eben Tessari Senior Vice President and Chief Operating Officer | 449.5K | — | 202.2K | 816.6K | 278.8K | 5.0K | 1.75M | 58.15% | ↗ |
| 18 | 2023 | Ross Moat Executive Vice President and Chief Commercial Officer | 436.6K | — | 183.8K | 742.2K | 243.1K | 25.5K | 1.63M | 56.77% | ↗ |
| 19 | 2022 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 835.5K | — | 922.0K | 3.75M | 597.4K | 12.2K | 6.11M | 76.36% | ↗ |
| 20 | 2022 | Sanj K. Patel Chief Executive Officer and Chairman of our Board of Directors | 834.9K | — | 922.0K | 3.75M | 597.4K | 12.2K | 6.11M | 76.37% | ↗ |
| 21 | 2022 | John F. Paolini, M.D., Ph.D. Executive Vice President and Chief Medical Officer | 515.7K | — | 230.5K | 936.3K | 226.9K | 12.2K | 1.92M | 60.72% | ↗ |
| 22 | 2022 | John F. Paolini, M.D. Senior Vice President and Chief Medical Officer | 514.6K | — | 230.5K | 936.3K | 226.9K | 12.2K | 1.92M | 60.76% | ↗ |
| 23 | 2022 | Eben Tessari Executive Vice President and Chief Operating Officer | 445.0K | — | 251.6K | 1.02M | 195.8K | 4.4K | 1.92M | 66.38% | ↗ |
| 24 | 2022 | Eben Tessari Senior Vice President and Chief Operating Officer | 443.5K | — | 251.6K | 1.02M | 195.8K | 4.4K | 1.92M | 66.43% | ↗ |
| 25 | 2022 | Mark Ragosa Senior Vice President and Chief Financial Officer | 444.2K | — | 248.6K | 1.01M | 195.4K | 12.2K | 1.91M | 65.89% | ↗ |
| 26 | 2022 | Ross Moat Executive Vice President and Chief Commercial Officer | 386.0K | — | 228.6K | 929.0K | 169.8K | 33.2K | 1.75M | 66.27% | ↗ |
| 27 | 2021 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 803.4K | — | 1.18M | 3.80M | 794.0K | 11.6K | 6.59M | 75.58% | ↗ |
| 28 | 2021 | John F. Paolini, M.D. Senior Vice President and Chief Medical Officer | 456.4K | — | 321.4K | 996.6K | 242.9K | 11.6K | 2.03M | 64.96% | ↗ |
| 29 | 2021 | Arian Pano, M.D. Senior Vice President and Chief Clinical Development Officer | 436.0K | — | 204.7K | 561.5K | 158.3K | 11.6K | 1.37M | 55.84% | ↗ |
| 30 | 2020 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 780.0K | — | — | 3.89M | 633.8K | 11.4K | 5.31M | 73.18% | ↗ |
| 31 | 2020 | Thomas Beetham Executive Vice President, Corporate Development & Operations, Chief Legal Officer and Secretary | 440.0K | — | — | 1.62M | 220.0K | 11.4K | 2.29M | 70.70% | ↗ |
| 32 | 2020 | Qasim Rizvi, MBChB., MBA Senior Vice President, Operations and Chief Commercial Officer | 432.0K | — | — | 1.62M | 189.0K | 11.4K | 2.25M | 71.93% | ↗ |
| 33 | 2019 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 780.0K | — | — | 3.52M | 456.3K | 11.2K | 4.77M | 73.82% | ↗ |
| 34 | 2019 | Stephen Mahoney Former President and Chief Operating Officer | 477.6K | — | — | 1.55M | — | 720.3K | 2.74M | 56.36% | ↗ |
| 35 | 2019 | John F. Paolini, M.D., Ph.D. Senior Vice President and Chief Medical Officer | 443.1K | — | — | 923.4K | 139.6K | 11.2K | 1.52M | 60.86% | ↗ |
| 36 | 2019 | Qasim Rizvi, MBChB., MBA Senior Vice President, Operations and Chief Commercial Officer | 392.7K | — | 95.1K | 880.9K | 123.7K | 11.2K | 1.50M | 64.91% | ↗ |
| 37 | 2018 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 740.5K | — | — | 5.81M | 742.5K | 11.0K | 7.31M | 79.56% | ↗ |
| 38 | 2018 | Stephen Mahoney President and Chief Operating Officer | 435.0K | — | — | 1.98M | 291.9K | 11.0K | 2.72M | 72.86% | ↗ |
| 39 | 2018 | Stephen Mahoney Former President and Chief Operating Officer | 435.0K | — | — | 1.98M | 291.9K | 11.0K | 2.72M | 72.86% | ↗ |
| 40 | 2018 | John F. Paolini, M.D., Ph.D. Senior Vice President and Chief Medical Officer | 409.6K | — | — | 1.88M | 207.9K | 11.0K | 2.50M | 74.90% | ↗ |
| 41 | 2018 | John F. Paolini, M.D., Ph.D Senior Vice President and Chief Medical Officer | 409.6K | — | — | 1.88M | 207.9K | 11.0K | 2.50M | 74.90% | ↗ |
| 42 | 2017 | Sanj K. Patel Chief Executive Officer and Chairman of the Board | 700.0K | — | — | 645.0K | 140.0K | 10.8K | 1.50M | 43.12% | ↗ |
| 43 | 2017 | John F. Paolini, M.D., Ph.D Senior Vice President and Chief Medical Officer | 380.0K | — | — | 275.4K | 114.0K | 10.8K | 780.2K | 35.30% | ↗ |
| 44 | 2017 | Stephen Mahoney President and Chief Operating Officer | 405.0K | — | — | 219.6K | 81.0K | 10.8K | 716.4K | 30.66% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sanj K. Patel | Chief Executive Officer & Chairman of the Board | 2M | male |
| Ross Michael Moat | Executive VP, COO & Principal Operating Officer | 1M | male |
| John F. Paolini | Executive Vice President & Chief Medical Officer | 1M | — |
| Eben Tessari | Consultant | 1M | male |
| Mark Ragosa | Executive VP & CFO | 1M | male |
| Joseph Pirrello | Chief Business Officer | — | male |
| Aaron Young | Chief Intellectual Property Officer | — | male |
| Martina Struck | Senior VP & Chief Regulatory Officer | — | female |
| Mei Jang | Senior VP & Chief Technical Officer | — | female |
| Michael R. Megna | Senior Vice President & Chief Accounting Officer | — | male |
| Randy Perrin | Group Vice President & Global Medical Affairs | — | male |
| Jonathan Kirshenbaum | Investor Relations Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KNSA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
